. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: Gynecol Oncol. 2016 May 8;142(1):76–82. doi: 10.1016/j.ygyno.2016.04.030

Table 2.

Univariate and Multivariate analysis of prognostic factors on overall survival

Variable	Univariate	Multivariate
Isolated versus Multifocal Brain Metastases	HR 0.33; CI 0.17–0.63, p=0.001	HR 2.66; CI 1.19– 5.93; p=0.017
CA-125 Level	HR 0.54; CI 0.30–0.95; p=0.03	ns
Ovarian versus Uterine versus Cervical primary	HR 3.28; CI 31.6–44.4, p=0.002	ns
Presenting Symptom: seizures, falls, or weakness vs. all other groups	HR 0.54; CI 0.32–0.91, p=0.02	ns
Single agent vs. multimodal therapy	HR 6.0; CI 1.62–5.9, p<0.001	ns

ns=not significant